MedTrace Logo

Iontophoretic Application of Acyclovir Gel to Treat Cold Sores

NCT00469300 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 810

Last updated 2008-02-04

No results posted yet for this study

Summary

Currently approved drugs for the treatment of herpes labialis (cold sores) exhibit low levels of efficacy due to the limited ability of the drugs to penetrate the skin to the sites where the herpes virus is replicating. Iontophoresis uses electric current to enhance delivery of drugs through the skin. This trial is testing a new iontophoretic device with a new acyclovir gel to treat cold sores.

Conditions

  • Herpes Labialis

Interventions

DRUG

Iontophoretic delivery of acyclovir

Sponsors & Collaborators

  • Transport Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Eric M Morrel, PhD · Transport Pharmaceuticals, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2007-09-30
Completion
2007-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00469300 on ClinicalTrials.gov